−3.77USD
−6.997MUSD
202.833K
About XORTX Therapeutics Inc.
Sector
CEO
Allen Warren Davidoff
Headquarters
Calgary
Website
Founded
2011
ISIN
CA98420Q3061
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
